Form 8K Entero Therapeutics Inc For: 16 July
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Entero Therapeutics Inc (ENTO)
Entero Therapeutics Inc stock price live, this page displays NASDAQ ENTO stock exchange data. View the ENTO premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Entero Therapeutics Inc real time stock price chart below.
What Is the Entero Therapeutics Inc Stock Price Today?
The Entero Therapeutics Inc stock price today is 0.3890.
What Is the Stock Symbol for Entero Therapeutics Inc?
The stock symbol for Entero Therapeutics Inc is ""ENTO.""
What Stock Exchange Does Entero Therapeutics Inc Trade On?
Entero Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Entero Therapeutics Inc a Good Stock to Buy?
Determining whether Entero Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ENTO quote. (ISIN: US33749P4081)
What Is the Entero Therapeutics Inc Stock Price Today?
The Entero Therapeutics Inc stock price today is 0.3890.
What Is the Stock Symbol for Entero Therapeutics Inc?
The stock symbol for Entero Therapeutics Inc is ""ENTO.""
What Stock Exchange Does Entero Therapeutics Inc Trade On?
Entero Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Entero Therapeutics Inc a Good Stock to Buy?
Determining whether Entero Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ENTO quote. (ISIN: US33749P4081)
NASDAQ
Currency in USD
0.3890
-0.0510(-11.59%)
Closed·
After Hours
0.3978+0.0088(+2.26%)
·
Fair Value
An estimate of a Entero Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.3700
0.4585
52 wk Range
0.2134
0.9260
ENTO Scorecard
Full Analysis
Suffers from weak gross profit margins
ENTO is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Entero Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.37000.4585
52 wk Range
0.21340.9260
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ENTO Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Entero Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to drop this year
- FluroTech Ltd. Announces Change in Directors
- Investing.com
- Form 8K Entero Therapeutics Inc For: 8 July
- Investing.com
- Form 8K Entero Therapeutics Inc For: 16 July
- Investing.com
- Form 8K Entero Therapeutics Inc For: 8 July
- Investing.com
- Form 8K Entero Therapeutics Inc For: 30 June
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Entero Therapeutics Inc Company Profile
Entero Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of targeted and non-systemic therapies for the treatment of patients with gastrointestinal diseases. It develops Adrulipase, an oral, non-systemic, and biologic capsule that is in Phase 2 clinical trials for the treatment of exocrine pancreatic insufficiency (EPI) in patients with cystic fibrosis (CF) and chronic pancreatitis (CP), as well as a recombinant lipase enzyme that enables the digestion of fats and other nutrients in CF and CP patients with EPI. The company was formerly known as First Wave BioPharma, Inc. and changed its name to Entero Therapeutics, Inc. in May 2024. Entero Therapeutics, Inc. was incorporated in 2014 and is headquartered in Boca Raton, Florida.
Compare ENTO to Peers and Sector
Metrics to compare | ENTO | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipENTOPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.1x | −4.0x | −0.5x | |
PEG Ratio | 0.00 | 0.01 | 0.00 | |
Price/Book | −0.4x | 3.2x | 2.6x | |
Price / LTM Sales | - | 151.9x | 3.3x | |
Upside (Analyst Target) | - | 147.7% | 43.4% | |
Fair Value Upside | Unlock | 2.7% | 7.1% | Unlock |
Earnings
Latest Release
May 15, 2025
EPS / Forecast
-0.26 / --
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Stock Exchange Does Entero Therapeutics Trade On?
Entero Therapeutics is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Entero Therapeutics?
The stock symbol for Entero Therapeutics is "ENTO."
What Is the Entero Therapeutics Market Cap?
As of today, Entero Therapeutics market cap is 1.85M.
What Is Entero Therapeutics's Earnings Per Share (TTM)?
The Entero Therapeutics EPS (TTM) is -5.40.
From a Technical Analysis Perspective, Is ENTO a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Entero Therapeutics Stock Split?
Entero Therapeutics has split 4 times.
How Many Employees Does Entero Therapeutics Have?
Entero Therapeutics has 2 employees.
What is the current trading status of Entero Therapeutics (ENTO)?
As of 08 Aug 2025, Entero Therapeutics (ENTO) is trading at a price of 0.39, with a previous close of 0.39. The stock has fluctuated within a day range of 0.37 to 0.46, while its 52-week range spans from 0.21 to 0.93.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.